Status:
COMPLETED
Cognitive Stimulation in Daily Activities for People Living With Early to Middle Stage Dementia
Lead Sponsor:
National University of Ireland, Galway, Ireland
Conditions:
Dementia
Dementia, Mild
Eligibility:
All Genders
Phase:
NA
Brief Summary
The goal of this study is to test the effect of CS-ADL is on people living with early to middle stage dementia. The study also aims to evaluate the feasibility of conducting larger-scale research of C...
Eligibility Criteria
Inclusion
- Participants must have a formal diagnosis of major neurocognitive disorder (dementia) as per the DSM-V criteria.
- Participants must have a mild-to-moderate cognitive impairment as classified by the Montreal Cognitive Assessment (MoCA).
- Participants must have some ability to communicate and understand communication, determined by a score of 1 or 0 on questions 12 and 13 of the Clifton Assessment Procedures for the Elderly-Behaviour Rating Scale.
- Participants must be able to see and hear well enough to participate in the group.
Exclusion
- Individuals with severe dementia, i.e., an MMSE\<10, will be excluded as most CS interventions are not applicable for those with severe cognitive impairment.
- Participants will be excluded if they have significant uncontrolled disruptive behaviours.
- Premorbid diagnosis of a learning disability.
- A significant physical illness/disability that may affect participation during intervention sessions or assessments.
Key Trial Info
Start Date :
November 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 21 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06147479
Start Date
November 3 2023
End Date
June 21 2024
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Galway
Galway, Connacht, Ireland